{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T09:37:56Z","timestamp":1786527476388,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Innovation Project of Guangxi Graduate Education of GXUCM","award":["No. YCBXJ2025014"],"award-info":[{"award-number":["No. YCBXJ2025014"]}]},{"name":"Health Commission Research Foundation of Guangxi","award":["No.Z-A20230153"],"award-info":[{"award-number":["No.Z-A20230153"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82260786\uff0c82460957"],"award-info":[{"award-number":["No. 82260786\uff0c82460957"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Guangxi Natural Science Foundation Project","award":["No. 2024GXNSFDA010005,No. 2023GXNSFBA026060, No.2025GXNSFAA069062"],"award-info":[{"award-number":["No. 2024GXNSFDA010005,No. 2023GXNSFBA026060, No.2025GXNSFAA069062"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to develop and validate a hypoxia-related gene signature for prognostic assessment in hepatocellular carcinoma (HCC) and to explore its associated biological characteristics and immune features. In addition, a self-established human tissue cohort was used to verify the expression stability of the identified signature genes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The TCGA-LIHC cohort was used as the training set to identify differentially expressed hypoxia-related genes associated with overall survival. Least absolute shrinkage and selection operator (LASSO) regression and Cox regression analyses were subsequently applied to construct a prognostic model. The predictive performance of the model was externally validated using the GSE14520 and GSE116174 cohorts. Functional enrichment and immune microenvironment analyses were performed to characterize the biological differences between risk groups. Furthermore, quantitative real-time PCR (qRT-PCR) was conducted in a human tissue cohort, including normal liver tissues, adjacent non-tumorous tissues, and HCC tissues, to validate the expression patterns of the four signature genes (TMEM45A, PPARGC1A, EFNA3, and STC2).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A four-gene hypoxia-related prognostic signature was established and successfully stratified patients into high- and low-risk groups. Patients in the high-risk group exhibited significantly poorer overall survival in both the training and validation cohorts. Functional enrichment analyses revealed that high-risk tumors were associated with activation of pathways related to cell-cycle progression, MYC targets, epithelial\u2013mesenchymal transition, and metabolic reprogramming. Immune analyses demonstrated increased M0 macrophage infiltration and elevated expression of multiple immune checkpoint genes in the high-risk group. qRT-PCR validation further confirmed the differential expression patterns of the four signature genes in human HCC tissues.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This four-gene hypoxia-related signature demonstrated robust prognostic performance across multiple independent cohorts and was associated with distinct metabolic and immune characteristics in HCC. qRT-PCR validation further supported the expression stability of the identified genes in human tissues. These findings provide a useful framework for prognostic stratification and future investigation of hypoxia-related biological mechanisms and therapeutic strategies in HCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12672-026-05691-w","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T12:12:47Z","timestamp":1786104767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel hypoxia-related signature for predicting prognosis, immune characteristics, and therapeutic response in hepatocellular carcinoma"],"prefix":"10.1007","volume":"17","author":[{"given":"Chengting","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longda","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewen","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3889-2446","authenticated-orcid":false,"given":"Yanfei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"5691_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102859","author":"C Kole","year":"2021","unstructured":"Kole C, Charalampakis N, Tsakatikas S, Vailas M, Moris D, Gkotsis E, et al. Immunotherapy for hepatocellular carcinoma: a 2021 update. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers12102859.","journal-title":"Cancers (Basel)"},{"key":"5691_CR2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i37.10573","author":"N Tsuchiya","year":"2015","unstructured":"Tsuchiya N. Biomarkers for the early diagnosis of hepatocellular carcinoma. World J Gastroenterol. 2015. https:\/\/doi.org\/10.3748\/wjg.v21.i37.10573.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"5691_CR3","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.gendis.2020.01.014","volume":"7","author":"W Wang","year":"2020","unstructured":"Wang W, Wei C. Advances in the early diagnosis of hepatocellular carcinoma. Genes Dis. 2020;7(3):308\u201319. https:\/\/doi.org\/10.1016\/j.gendis.2020.01.014.","journal-title":"Genes Dis"},{"issue":"43","key":"5691_CR4","doi-asserted-by":"publisher","first-page":"15955","DOI":"10.3748\/wjg.v20.i43.15955","volume":"20","author":"M Schlageter","year":"2014","unstructured":"Schlageter M, Terracciano LM, D\u2019Angelo S, Sorrentino P. Histopathology of hepatocellular carcinoma. World J Gastroenterol. 2014;20(43):15955\u201364. https:\/\/doi.org\/10.3748\/wjg.v20.i43.15955.","journal-title":"World J Gastroenterol"},{"issue":"1035","key":"5691_CR5","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20130676","volume":"87","author":"SR McKeown","year":"2014","unstructured":"McKeown SR. Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response. Br J Radiol. 2014;87(1035):20130676. https:\/\/doi.org\/10.1259\/bjr.20130676.","journal-title":"Br J Radiol"},{"issue":"12","key":"5691_CR6","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1136\/gutjnl-2016-313264","volume":"66","author":"CP Cui","year":"2017","unstructured":"Cui CP, Wong CC, Kai AK, Ho DW, Lau EY, Tsui YM, et al. SENP1 promotes hypoxia-induced cancer stemness by HIF-1\u03b1 deSUMOylation and SENP1\/HIF-1\u03b1 positive feedback loop. Gut. 2017;66(12):2149\u201359. https:\/\/doi.org\/10.1136\/gutjnl-2016-313264.","journal-title":"Gut"},{"issue":"2","key":"5691_CR7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jhep.2010.10.043","volume":"55","author":"J Wang","year":"2011","unstructured":"Wang J, Ma Y, Jiang H, Zhu H, Liu L, Sun B, et al. Overexpression of von Hippel-Lindau protein synergizes with doxorubicin to suppress hepatocellular carcinoma in mice. J Hepatol. 2011;55(2):359\u201368. https:\/\/doi.org\/10.1016\/j.jhep.2010.10.043.","journal-title":"J Hepatol"},{"issue":"6","key":"5691_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325. https:\/\/doi.org\/10.1016\/j.cels.2015.12.004.","journal-title":"Cell Syst"},{"key":"5691_CR9","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1016\/j.csbj.2024.06.035","volume":"23","author":"H Liu","year":"2024","unstructured":"Liu H, Zhang W, Zhang Y, Adegboro AA, Fasoranti DO, Dai L, et al. Mime: a flexible machine-learning framework to construct and visualize models for clinical characteristics prediction and feature selection. Comput Struct Biotechnol J. 2024;23:2798\u2013810. https:\/\/doi.org\/10.1016\/j.csbj.2024.06.035.","journal-title":"Comput Struct Biotechnol J"},{"issue":"9","key":"5691_CR10","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.21037\/tcr-21-741","volume":"10","author":"J Wang","year":"2021","unstructured":"Wang J, Li Y, Zhang C, Chen X, Zhu L, Luo T. A hypoxia-linked gene signature for prognosis prediction and evaluating the immune microenvironment in patients with hepatocellular carcinoma. Transl Cancer Res. 2021;10(9):3979\u201392. https:\/\/doi.org\/10.21037\/tcr-21-741.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"5691_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10195-1","volume":"22","author":"G Zhang","year":"2022","unstructured":"Zhang G, Zhang K, Zhao Y, Yang Q, Lv X. A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma. BMC Cancer. 2022;22(1):1103. https:\/\/doi.org\/10.1186\/s12885-022-10195-1.","journal-title":"BMC Cancer"},{"issue":"1","key":"5691_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-023-03090-x","volume":"21","author":"K Li","year":"2023","unstructured":"Li K, Yang Y, Ma M, Lu S, Li J. Hypoxia-based classification and prognostic signature for clinical management of hepatocellular carcinoma. World J Surg Oncol. 2023;21(1):216. https:\/\/doi.org\/10.1186\/s12957-023-03090-x.","journal-title":"World J Surg Oncol"},{"issue":"17","key":"5691_CR13","doi-asserted-by":"publisher","first-page":"5663","DOI":"10.2147\/JIR.S476388","volume":"27","author":"S Wang","year":"2024","unstructured":"Wang S, Ye W, Yang K, Lv X, Luan J. Prognostic hypoxia-angiogenesis-related gene signature in hepatocellular carcinoma, in which HILPDA contributes to tumor progression. J Inflamm Res. 2024;27(17):5663\u201383. https:\/\/doi.org\/10.2147\/JIR.S476388.","journal-title":"J Inflamm Res"},{"issue":"7","key":"5691_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0288013","volume":"18","author":"Y Liu","year":"2023","unstructured":"Liu Y, Shen B, Huang T, Wang J, Jiang J. Construction and validation of 3-genes hypoxia-related prognostic signature to predict the prognosis and therapeutic response of hepatocellular carcinoma patients. PLoS ONE. 2023;18(7):e0288013. https:\/\/doi.org\/10.1371\/journal.pone.0288013.","journal-title":"PLoS ONE"},{"key":"5691_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.637418","volume":"12","author":"Y Bai","year":"2021","unstructured":"Bai Y, Qi W, Liu L, Zhang J, Pang L, Gan T, et al. Identification of seven-gene hypoxia signature for predicting overall survival of hepatocellular carcinoma. Front Genet. 2021;12:637418. https:\/\/doi.org\/10.3389\/fgene.2021.637418.","journal-title":"Front Genet"},{"issue":"1","key":"5691_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02492-9","volume":"18","author":"B Zhang","year":"2020","unstructured":"Zhang B, Tang B, Gao J, Li J, Kong L, Qin L. A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients. J Transl Med. 2020;18(1):342. https:\/\/doi.org\/10.1186\/s12967-020-02492-9.","journal-title":"J Transl Med"},{"key":"5691_CR17","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1016\/j.csbj.2021.03.033","volume":"19","author":"F Zeng","year":"2021","unstructured":"Zeng F, Zhang Y, Han X, Zeng M, Gao Y, Weng J. Employing hypoxia characterization to predict tumour immune microenvironment, treatment sensitivity and prognosis in hepatocellular carcinoma. Comput Struct Biotechnol J. 2021;19:2775\u201389. https:\/\/doi.org\/10.1016\/j.csbj.2021.03.033.","journal-title":"Comput Struct Biotechnol J"},{"issue":"11","key":"5691_CR18","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20221089","volume":"42","author":"J Xing","year":"2022","unstructured":"Xing J, Shen S, Liu X, Zhang Y. A hypoxia-related prognostic model predicts overall survival and treatment response in hepatocellular carcinoma. Biosci Rep. 2022;42(11):BSR20221089. https:\/\/doi.org\/10.1042\/BSR20221089.","journal-title":"Biosci Rep"},{"issue":"1","key":"5691_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13062-024-00518-6","volume":"19","author":"Z Liu","year":"2024","unstructured":"Liu Z, Sun L, Zhu W, Zhu J, Wu C, Peng X, et al. Disulfidptosis signature predicts immune microenvironment and prognosis of gastric cancer. Biol Direct. 2024;19(1):65. https:\/\/doi.org\/10.1186\/s13062-024-00518-6.","journal-title":"Biol Direct"},{"issue":"2","key":"5691_CR20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1089\/jir.2022.0172","volume":"43","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang Q, Yang TW, Yin JM, Wei F, Liu H, et al. Analysis of immune and inflammatory microenvironment characteristics of noncancer end-stage liver disease. J Interferon Cytokine Res. 2023;43(2):86\u201397. https:\/\/doi.org\/10.1089\/jir.2022.0172.","journal-title":"J Interferon Cytokine Res"},{"issue":"4","key":"5691_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14489","volume":"30","author":"WW Duan","year":"2024","unstructured":"Duan WW, Yang LT, Liu J, Dai ZY, Wang ZY, Zhang H, et al. A TGF-\u03b2 signaling-related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response. CNS Neurosci Ther. 2024;30(4):e14489. https:\/\/doi.org\/10.1111\/cns.14489.","journal-title":"CNS Neurosci Ther"},{"key":"5691_CR22","doi-asserted-by":"publisher","unstructured":"Flamant L, Roegiers E, Pierre M, Hayez A, Sterpin C, De Backer O, et al. TMEM45A is essential for hypoxia-induced chemoresistance in breast and liver cancer cells. BMC Cancer. 2012;6(12):391. https:\/\/doi.org\/10.1186\/1471-2407-12-391.","DOI":"10.1186\/1471-2407-12-391"},{"issue":"20","key":"5691_CR23","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1038\/onc.2014.200","volume":"34","author":"L G\u00f3mez-Maldonado","year":"2015","unstructured":"G\u00f3mez-Maldonado L, Tiana M, Roche O, Prado-Cabrero A, Jensen L, Fernandez-Barral A, et al. EFNA3 long noncoding RNAs induced by hypoxia promote metastatic dissemination. Oncogene. 2015;34(20):2609\u201320. https:\/\/doi.org\/10.1038\/onc.2014.200.","journal-title":"Oncogene"},{"issue":"3","key":"5691_CR24","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.yexcr.2009.09.018","volume":"316","author":"AY Law","year":"2010","unstructured":"Law AY, Wong CK. Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia. Exp Cell Res. 2010;316(3):466\u201376. https:\/\/doi.org\/10.1016\/j.yexcr.2009.09.018.","journal-title":"Exp Cell Res"},{"issue":"2","key":"5691_CR25","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s12035-019-01731-5","volume":"57","author":"SM Soyal","year":"2020","unstructured":"Soyal SM, Bonova P, Kwik M, Zara G, Auer S, Scharler C, et al. The expression of CNS-specific PPARGC1A transcripts is regulated by hypoxia and a variable GT repeat polymorphism. Mol Neurobiol. 2020;57(2):752\u201364. https:\/\/doi.org\/10.1007\/s12035-019-01731-5.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"5691_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41575-018-0089-3","volume":"16","author":"E Piccinin","year":"2019","unstructured":"Piccinin E, Villani G, Moschetta A. Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators. Nat Rev Gastroenterol Hepatol. 2019;16(3):160\u201374. https:\/\/doi.org\/10.1038\/s41575-018-0089-3.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"5691_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18042","volume":"28","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Tan H, Zhang X, Zhu J. Roles of peroxisome proliferator-activated receptors in hepatocellular carcinoma. J Cell Mol Med. 2024;28(5):e18042. https:\/\/doi.org\/10.1111\/jcmm.18042.","journal-title":"J Cell Mol Med"},{"issue":"12","key":"5691_CR28","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41575-019-0217-8","volume":"16","author":"L Satriano","year":"2019","unstructured":"Satriano L, Lewinska M, Rodrigues PM, Banales JM, Andersen JB. Metabolic rearrangements in primary liver cancers: cause and consequences. Nat Rev Gastroenterol Hepatol. 2019;16(12):748\u201366. https:\/\/doi.org\/10.1038\/s41575-019-0217-8.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5691_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2024.110149","volume":"761","author":"D Li","year":"2024","unstructured":"Li D, Xiong Y, Li M, Long L, Zhang Y, Yan H, et al. STC2 knockdown inhibits cell proliferation and glycolysis in hepatocellular carcinoma through promoting autophagy by PI3K\/Akt\/mTOR pathway. Arch Biochem Biophys. 2024;761:110149. https:\/\/doi.org\/10.1016\/j.abb.2024.110149.","journal-title":"Arch Biochem Biophys"},{"issue":"9","key":"5691_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2147\/JHC.S351882","volume":"8","author":"Z Wu","year":"2022","unstructured":"Wu Z, Cheng H, Liu J, Zhang S, Zhang M, Liu F, et al. The oncogenic and diagnostic potential of stanniocalcin 2 in hepatocellular carcinoma. J Hepatocell Carcinoma. 2022;8(9):141\u201355. https:\/\/doi.org\/10.2147\/JHC.S351882.","journal-title":"J Hepatocell Carcinoma"},{"key":"5691_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2025.118209","volume":"296","author":"X Zhou","year":"2025","unstructured":"Zhou X, Wei C, Liu X, Zhang Z, Wu Y, Zeng B, et al. Revealing the role of bisphenol A on prostate cancer progression and identifying potential targets: a comprehensive analysis from population cohort to molecular mechanism. Ecotoxicol Environ Saf. 2025;296:118209. https:\/\/doi.org\/10.1016\/j.ecoenv.2025.118209.","journal-title":"Ecotoxicol Environ Saf"},{"key":"5691_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2024.129742","volume":"104","author":"Q Dai","year":"2024","unstructured":"Dai Q, Yuan Z, Sun Q, Ao Z, He B, Jiang Y. Discovery of novel nucleoside derivatives as selective lysine acetyltransferase p300 inhibitors for cancer therapy. Bioorg Med Chem Lett. 2024;104:129742. https:\/\/doi.org\/10.1016\/j.bmcl.2024.129742.","journal-title":"Bioorg Med Chem Lett"},{"issue":"12","key":"5691_CR33","doi-asserted-by":"publisher","first-page":"7511","DOI":"10.62347\/PLQF5135","volume":"16","author":"G Liu","year":"2024","unstructured":"Liu G, Long J, Liu C, Chen J. Development and verification of a nomogram for predicting portal vein tumor thrombosis in hepatocellular carcinoma. Am J Transl Res. 2024;16(12):7511\u201320. https:\/\/doi.org\/10.62347\/PLQF5135.","journal-title":"Am J Transl Res"},{"issue":"10","key":"5691_CR34","doi-asserted-by":"publisher","first-page":"1107128","DOI":"10.3389\/fmed.2023.1107128","volume":"15","author":"PS Ramalingam","year":"2023","unstructured":"Ramalingam PS, Priyadharshini A, Emerson IA, Arumugam S. Potential biomarkers uncovered by bioinformatics analysis in sotorasib resistant-pancreatic ductal adenocarcinoma. Front Med (Lausanne). 2023;15(10):1107128. https:\/\/doi.org\/10.3389\/fmed.2023.1107128.","journal-title":"Front Med (Lausanne)"},{"key":"5691_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108198","volume":"171","author":"H Gong","year":"2024","unstructured":"Gong H, Liu Z, Yuan C, Luo Y, Chen Y, Zhang J, et al. Identification of cuproptosis-related lncRNAs with the significance in prognosis and immunotherapy of oral squamous cell carcinoma. Comput Biol Med. 2024;171:108198. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108198.","journal-title":"Comput Biol Med"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05691-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05691-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05691-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T09:08:54Z","timestamp":1786525734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05691-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5691"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05691-w","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"5 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol involving human tissue samples was approved by the Institutional Ethics Committee of Guangxi University of Chinese Medicine (Approval No. GXTCMU-EC KS20250000-525). The study was conducted in accordance with the Declaration of Helsinki and relevant ethical guidelines.Written informed consent was obtained from all participants prior to tissue sample collection.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were performed in accordance with relevant institutional, national, and international guidelines and regulations.","order":4,"name":"Ethics","label":"Accordance statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1168"}}